Evidence map›Paper›PMID 28962270›Full record

ArticleToxicology reports2014

Naringenin accords hepatoprotection from streptozotocin induced diabetes in vivo by modulating mitochondrial dysfunction and apoptotic signaling cascade.

Radhika Kapoor, Poonam Kakkar

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Meta-analysis Flavonoids from traditional Chinese herbs for diabetes in rats: a network Meta-analysi.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Article
  14. Article
  15. Review
  16. Phytochemical and Ethnopharmacological Perspectives ofMolecules (Basel, Switzerland) · 2021
    Review
  17. Article
  18. Review
  19. Article
  20. Antidiabetic Potency, Antioxidant Effects, and Mode of Actions ofOxidative medicine and cellular longevity · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Radhika KapoorCSIR-Indian Institute of Toxicology Research, M.G. Marg, Lucknow 226001, India.
Poonam KakkarCSIR-Indian Institute of Toxicology Research, M.G. Marg, Lucknow 226001, India.
Indian Institute of Toxicology Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic complications cause noticeable liver damage, which finally progresses to diabetic hepatopathy. Nutritive antioxidants not only reduce the liver damage, but also prevent it by modulating the release of various proteins involved in apoptotic signaling cascades. This study explores the molecular mechanisms underlying diabetes-induced liver damage and its modulation by naringenin. Antioxidant status, liver & kidney biomarker enzymes, reactive oxygen species (ROS) generation, mitochondrial membrane potential, expression of apoptotic proteins like Bax (bcl-2 associated X), Bcl-2 (b-cell Lymhoma-2), Caspase-3, Caspase-9, AIF (Apoptosis inducing factor) and Endo-G (Endonuclease-G) were studied in streptozotocin induced diabetic rats. Significant hyperglycemia, disturbed antioxidant status, altered carbohydrate metabolizing enzymes, increased ROS and lipid peroxidation; decreased mitochondrial membrane potential and enhanced release of AIF and Endo-G were observed. Hyperglycemia also affected apoptosis and its related genes at both transcriptional and translational level (Caspase-3 & 9, Bax and Bcl-2) in the liver of diabetic rats. Naringenin, a flavonone, exerted anti-hyperglycemic effect and was able to prevent oxidative stress and resultant apoptotic events caused due to diabetes-induced hepatotoxicity. Thus, our study shows, a protective effect of naringenin against diabetes induced liver damage and redox imbalance, which could further be exploited for the management of diabetic hepatopathy.

Indexed as

AGE, advanced glycated end productsAIF, apoptosis inducing factorApoptosisBax, bcl-2 associated XBcl-2, b-cell Lymhoma-2CAT, catalasecDNA, complementaryCoN, diabetic rats co-treated with naringenin during streptozotocin inductionCtN, control rats treated with naringeninCtrl, control ratsDCF, dichlorofluoresceinDCFH-DA, 2′7′dichlorofluorescein diacetated-glucose (PubChem CID: 5793)Diab, diabetic ratsDNA,COX-II, cyclo-oxygenase-IIEDTA, ethylenediaminetetraacetic acidEndo-G, endonuclease-GFITC, fluorescein isothiocyanateGAPDH, glyceraldehyde 3 phosphate dehydrogenaseGlib, diabetic rats treated with standard drug glybenclamideGlibenclamide (PubChem CID: 3488)GPx, glutathione peroxidaseGSH, reduced glutathioneHRP, horseradish peroxidaseJC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazol-carbocyanine iodideLiver damageMitochondrial dysfunctionMPT, mitochondrial permeability transitionNADPH, nicotinamide adenine dinucleotide phosphate reducedNADPH (PubChem CID: 12598259)NaringeninNaringenin (PubChem CID: 932)NBT, nitroblue tetrazoliumNicotinamide (PubChem CID: 936)Oxidative stressPBS, phosphate buffered salinePKC, protein kinase-Cp-NA, p-nitro anilinePoN, diabetic rats treated with naringenin after diabetes inductionPVDF, polyvinylidene difluorideROS, reactive oxygen speciesRT-PCR, reverse transciptase polymerase chain reactionSil, diabetic rats treated with silymarinSilymarin (PubChem CID: 1548894)Sodium dodecyl sulphate (PubChem CID: 3423265)SOD, superoxide dismutaseStreptozotocin induced diabetesStreptozotocin (PubChem CID: 29327)Thiobarbituric acid (PubChem CID: 3081198)TriChloroacetic acid (PubChem CID: 6421)ΨΔm, mitochondrial membrane potential

Identifiers

PMID28962270
PMCPMC5598533
OpenAlexW2095176667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.